Back

Clinical and real-world evidence for the treatment of ATTR-CM

20 May 2023 (13:05 - 13:25)
Organised by: Logo
Congress Presentation Part of: Heart failure and ATTR-CM: recognizing an underdiagnosed condition Myocardial Disease Open Access Heart Failure 2023 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Pablo Garcia-Pavia

Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda (Spain)

4 More presentations in this session

Presentation thumbnail
Understanding the prevalence and burden of cardiac amyloidosis
Professor A. Linhart (Prague, CZ)
Slides
Presentation thumbnail
Expert perspectives on red flags for ATTR-CM: a practical approach
Professor S. Perlini (Pavia, IT)
Slides
Presentation thumbnail
Facilitating non-invasive diagnosis of ATTR-CM through specialist collaboration
Doctor R. Bonfiglioli (Bologna, IT)
Slides
Presentation thumbnail
Q&A
Slides

Access the full session

Session thumbnail
Heart failure and ATTR-CM: recognizing an underdiagnosed condition
Video

The Event

Event poster

Heart Failure 2023

20 May 2023 13:05 CET
You may be interested in
thumbnail
Congress Presentation
Evolving the understanding of TTR's role in health and disease​
31 August 2025
thumbnail
Congress Session
Evolving treatment paradigms in heart failure: from SGLT2 inhibition to transthyretin stabilisation and beyond
20 May 2025
thumbnail
Congress Session
ATTRibutes of change: advances in treating and monitoring ATTR-CM
17 May 2025
thumbnail
Congress Presentation
Clinical presentation and treatment landscape of patients with transthyretin amyloidosis with cardiomyopathy: a real-world study in five European countries and Japan
18 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources